Breakthroughs are changing the physicians treatment approach
Phase 3 COAST trial fails to meet primary endpoints for wet AMD, Opthea reports
The Combination OPT-302 with Aflibercept Study (COAST) evaluated sozinibercept 2 mg in combination with aflibercept 2 mg for wet age-related macular degeneration
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Increased paediatric astigmatism prevalence and severity after COVID-19
The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in childhood astigmatisms
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Three researchers receive 2025 ARVO Foundation Early Career Clinician-Scientist Awards
The award recipients are leading research projects in India, Italy and Mexico
Bausch + Lomb launches Arise orthokeratology lens fitting system in Europe, UK and US
The Arise system utilises advanced algorithms to interpret corneal topography images, recommending lenses without requiring a fitting set
